Seres Therapeutics, Inc. (MCRB) › Shares OutstandingSeres Therapeutics, Inc. (MCRB) — Shares OutstandingAnnual figures by fiscal year, from SEC filings.2014: 6.89M2015: 39.08M2016: 40.36M2017: 40.57M2018: 40.94M2019: 70.14M2020: 91.46M2021: 91.89M2022: 125.22M2023: 135.04M2024: 8.65M2025: 9.56M9.56M2014Shares Outstanding (shares)2025Fiscal YearShares OutstandingChange YoY20259.56M+10.5%20248.65M-93.6%2023135.04M+7.8%2022125.22M+36.3%202191.89M+0.5%202091.46M+30.4%201970.14M+71.3%201840.94M+0.9%201740.57M+0.5%201640.36M+3.3%201539.08M+467.2%20146.89M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresDividends Per Share